Therapeutical implications of melatonin in alzheimer’s and parkinson’s diseases
Abstract: Neurodegenerative diseases like Alzheimer’s disease (AD) and Parkinson’s disease (PD) are major health problems, and a growing recognition exists that efforts to prevent them must be undertaken by both governmental and nongovernmental organizations. In this context, the pineal product mela...
Guardado en:
| Autores principales: | Cardinali, Daniel Pedro, Vigo, Daniel Eduardo, Olivar, Natividad, Vida, María F., Brusco, Luis I. |
|---|---|
| Formato: | Parte de libro |
| Lenguaje: | Inglés |
| Publicado: |
Humana Press
2020
|
| Materias: | |
| Acceso en línea: | https://repositorio.uca.edu.ar/handle/123456789/10188 |
| Aporte de: |
Ejemplares similares
-
Melatonin : clinical perspectives in neurodegeneration
por: Cardinali, Daniel Pedro
Publicado: (2019) -
Melatonin therapy in patients with Alzheimer's disease
por: Cardinali, Daniel Pedro, et al.
Publicado: (2019) -
Melatonin antioxidative defense : therapeutical implications for aging and neurodegenerative processes
por: Pandi Perumal, Seithikurippu R., et al.
Publicado: (2019) -
Melatonin as a chronobiotic and cytoprotective agent in Parkinson’s disease
por: Pérez Lloret, Santiago, et al.
Publicado: (2021) -
An assessment of melatonin's therapeutic value in the hypoxic-Ischemic encephalopathy of the newborn
por: Cardinali, Daniel Pedro
Publicado: (2020)